Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Scleroderma Relat Disord ; 6(2): 214-219, 2021 Jun 01.
Article in English | MEDLINE | ID: mdl-34350365

ABSTRACT

Many studies have demonstrated an increased risk of cancer in patients with rheumatologic diseases, including systemic sclerosis. Less explored is the role of immunosuppressive therapy as a contributing factor in cancer emergence or detection. This series introduces two cases of patients with systemic sclerosis who demonstrated clinical improvement in their rheumatic disease process with immunosuppression, but both of whom developed neurologic symptoms in the setting of decreasing or discontinuing immunosuppressive therapy, leading to the ultimate diagnosis of Epstein Barr Virus positive (EBV+) diffuse large B cell lymphoma of the CNS. To our knowledge, primary CNS lymphoma has not been previously described in systemic sclerosis patients. Immunosuppressive therapies could promote the development of virus-associated malignancies due to decreased viral clearance. We hypothesize that removing immunosuppression could allow the immune system to generate an inflammatory response to an underlying tumor or viral antigen, contributing to development of neurologic symptoms and detection of underlying disease.

2.
Am J Surg ; 211(6): 1035-40, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26746568

ABSTRACT

BACKGROUND: The management and outcomes of patients receiving nonelective surgical treatment of acute complicated diverticulitis by surgeon specialization have received little attention. METHODS: A retrospective review was performed of consecutive patients with acute complicated diverticulitis who underwent surgery from 2006 to 2013. Patients were analyzed based on surgeon specialty: general surgery (GS) or colorectal surgery (CRS). RESULTS: One hundred fifteen patients met criteria for study; 62 patients in the CRS and 53 in the GS group. GS were more likely to perform Hartmann's procedures or primary anastomosis and less likely to perform primary anastomosis with diverting ileostomy than CRS. There were no differences between groups for any outcome measures on univariate analysis. CRS patients had shorter operative time (P = .001) and length of stay (P ≤ .001) for stoma reversal procedures. Surgeon specialization was not associated with morbidity, readmission, or length of stay on multivariate analysis. CONCLUSIONS: Although surgical management differed significantly between CRS and GS, comparable outcomes were observed at the index hospital admission.


Subject(s)
Colorectal Surgery/standards , Diverticulitis, Colonic/mortality , Diverticulitis, Colonic/surgery , General Surgery/standards , Hospital Mortality , Acute Disease , Adult , Aged , Cohort Studies , Colorectal Surgery/trends , Diverticulitis, Colonic/diagnosis , Female , Follow-Up Studies , General Surgery/trends , Humans , Logistic Models , Male , Middle Aged , Multivariate Analysis , Operative Time , Postoperative Complications/mortality , Postoperative Complications/physiopathology , Retrospective Studies , Risk Assessment , Severity of Illness Index , Specialties, Surgical , Statistics, Nonparametric , Survival Analysis , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...